From a molecular pharmacy standpoint, Relafen 750 (the active ingredient) represents a fascinating case of how targeted drug action can reduce discomfort. Its mechanism primarily involves the inhibition of cyclooxygenase (prostaglandin-synthesizing enzymes), specifically COX-2, reducing the production of inflammatory mediators. This specific inhibi

From a biochemical drugstore viewpoint, Relafen 750, containing naproxen, signifies a fascinating case study in drug action. Its main mechanism involves blocking cyclooxygenase (COX) enzymes, specifically COX-2, which results in reduced generation of prostaglandins . This targeted inhibition reduces tenderness and discomfort associated with conditi